TRACE is the first multi-national clinical trial to prove efficacy and safety of Adoptive T-cell transfer in immunocompromised individuals. TRACE will provide data, ethical and regulatory approvals and logistic infrastructure to build the basis .....
TRACE - Adoptive Transfer of multivirus-specific T cells against Adenovirus, Cytomegalovirus and Epstein-Barr Virus